MarketInOut Stock Screener Log In | Sign Up

Bausch Health Cos. Inc

IEX • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/30/2026
Bausch Health Cos. Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeIEX
Market Capitalization3,221.46 mln
Float331 mln
Earnings Date02/24/2027

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-3.01
Reliable

1-Year Forecast

7.70
Limited downside

Relative Strength

99 / 100
Top performer

Pre-Tax Margin

-3%
Barely loss-making

ROE

-11,040
Deeply negative

Business Description

Bausch Health Companies Inc. is a Canada-based company that makes and sells prescription drugs, over-the-counter medicines, and medical devices across the United States and many other countries. Its products cover a wide range of health areas, including digestive health, skin care, neurology, and eye care, with eye health operating under the well-known Bausch + Lomb brand. The company also sells aesthetic medical devices through its Solta Medical division.

Key Fundamentals

EPS-2.26
ROE-11,040
RPS29.73
ROIC12.88
ROA-3.19
Interest Cover1.89
EBITDA, mln2,396
EV / EBITDA9.52
EV / EBIT18.30
Revenue, mln11,113
EV / Revenue2.05

Quote Details

Last 8.21
Change -0.7 (-7.86%)
Open 8.93
Volume 7,993,505
Turnover 65,626,680
Average Volume 3,255,542

Financial Ratios

Pre-Tax Profit Margin-3
Current Ratio1.56
Price / Cash Flow1.46
Price / Free Cash Flow1.80
Price / Sales0.30
PEG Ratio1.15

Financial Strength

Altman Z-Score0.2
Piotroski F-Score 5 / 9
Beneish M-Score-3.01
Price to Intrinsic Value0.53
1-Year Target Price7.70
Short Ratio4.46
Short % of Float2.75

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 27.48% 99 / 100   
1 Month 43.28% 99 / 100   
2 Months 83.26% 99 / 100   
6 Months 44.54% 95 / 100   
1 Year 39.15% 81 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog